Tranexamic acid prophylaxis in heme malignancies, N-glycosylation as a therapeutic vulnerability in CALR-mutant MPN, and myocardial fibrosis in sickle cell anemia

episode

Blood Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-24-2026 11PM EDT 5 min · 25 Sep 2026 · NPR News Now

Microsoft AI Boss: “A Silicon Species” Could Compete With HumansMicrosoft AI Boss: “A Silicon Species” Could Compete With Humans 38 min · 25 Sep 2026 · AI Haven't A Clue

Who are the "passport bros" travelling abroad to find love? 5 min · 25 Sep 2026 · Do you really know?

Can plate colour really affect our sense of taste? 5 min · 25 Sep 2026 · Do you really know?

Is a white tongue unhealthy? 2 min · 25 Sep 2026 · Do you really know?

After 2 Years of Interviewing Health Experts, Here’s What I Actually Believe 58 min · 25 Sep 2026 · Culture Apothecary with Alex Clark

Report any issue

Source

Recorded15 Sep 2022

Publisherfeeds.transistor.fm ↗

Handlerec:11742069

Show notes

In this week’s episode we’ll discuss the efficacy of tranexamic acid prophylaxis in patients with hematological malignancies, learn more about N-glycosylation as a therapeutic vulnerability in CALR-mutant MPN, and discuss how early initiation of disease-modifying therapy may be able to reduce myocardial fibrosis in sickle cell anemia.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in